Breaking News on Contract Research, Manufacturing & Clinical Trials

All news > Audios

Liquent and Take Solutions team on regulatory submissions

Liquent and Take Solutions team on regulatory submissions

Jeff Huntsman

VP sales and marketing - Liquent

Liquent and Take Solutions say their new partnership provides pharmaceutical firms with an efficient, cost effective outsourced solution for regulatory publication and submissions.

Published: 24-Mar-2010

INC forms ePRO partnership with invivodata

INC forms ePRO partnership with invivodata

Alistair Macdonald

Executive Vice President, Strategic Development - INC Research

INC Research is partnering with invivodata to add ePRO to its offering, selecting the eClinical firm over its competitors in part because it understands the “aggressive” approach the CRO takes.

Published: 16-Mar-2010

Centralising ECG trial data can cut costs 40%, says ERT

Centralising ECG trial data can cut costs 40%, says ERT

John Blakeley

Executive VP sales and marketing - E Research Technology

E Research Technology (ERT) launches Centralised Cardiac Safety 2.0 (CCS 2.0) service for ECG data and says approach improves efficiency, cuts costs and helps sponsors reach database lock quicker than distributed model.

Published: 15-Mar-2010

Quintiles opens Nairobi office

Quintiles opens Nairobi office

Gillian Corken

CEO - Quintiles Africa

Contract services giant Quintiles has continued its expansion in Africa with a new clinical research services office in Nairobi, Kenya.

Published: 11-Mar-2010

Adaptive approach to trial design and operation is key, Health Decisions

Adaptive approach to trial design and operation is key, Health Decisions

Michael Rosenberg

CEO - Health Decisions

An adaptive approach to both the design and operation of a clinical trial can boost efficiency, reduce timelines and cut costs says Health Decisions' CEO Michael Rosenberg.

Published: 10-Mar-2010

Electronic submission offers benefits for pharma, says ISI

Electronic submission offers benefits for pharma, says ISI

Kate Wilber

Director of European Regulatory Services - Image Solutions

Drug firms continue to make basic errors in their electronic submissions according to French regulatory group the AFSSAPS, which said recently that it returns half the NeeS dossiers it receives as they do not meet basic validation standards.

Published: 09-Mar-2010

SAFC preparing for inevitable shift to cell culture vaccines

SAFC preparing for inevitable shift to cell culture vaccines

David Backer

Director of Business Development and Marketing - SAFC Pharma

SAFC Pharma is preparing for the shift towards cell culture-based vaccines, while still supplying and growing in the traditional sector, to ensure it can grow in coming years, according to a company director.

Published: 25-Feb-2010

Informex – companies hope for a brighter 2010

Informex – companies hope for a brighter 2010

There are signs that 2010 will be a better year for the fine and custom chemistry industry but companies at Informex remained cautious and are planning accordingly.

Published: 22-Feb-2010

MDS' sites "perfectly dovetail" with Ricerca's capacity; VP

MDS' sites "perfectly dovetail" with Ricerca's capacity; VP

Mark Crane

VP business development and marketing - Ricerca

The capabilities of the MDS Pharma Services' sites Ricerca is set to acquire "perfectly dovetail" with its existing capacity, according to a company vice president.

Published: 17-Feb-2010

Trial sponsors and CROs must do more to recruit older people, says EU group

Trial sponsors and CROs must do more to recruit older people, says EU group

Professor Peter Crome

European Union PREDICT group - Keele University, UK

Clinical trials are often biased against the recruitment of older people says the European Union's PREDICT group, which has launched a charter designed to protect such patients' right to take part.

Published: 16-Feb-2010

MENA emerging as trial destination says ClinTec CEO

MENA emerging as trial destination says ClinTec CEO

Dr Rabinder Buttar

CEO - ClinTec International

Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.

Published: 08-Feb-2010

Adaptive methods can improve personalised medicine trials; CEO

Adaptive methods can improve personalised medicine trials; CEO

Michael Rosenberg

CEO - Health Decisions

Conducting trials in smaller patient populations when developing personalised medicines poses challenges, such as how to recruit patients fast enough, but these can be overcome using adaptive methods, according to a CEO.

Published: 14-Jan-2010

14 C "synth to clinic" simplifies development process, says Quotient CEO

14 C "synth to clinic" simplifies development process, says Quotient CEO

Paul Cowan

CEO - Quotient Bioresearch

UK contract services firm Quotient Bioresearch says its "Synthesis-to-clinic" service for 14 C labelled compounds can simplify early drug development.

Published: 24-Nov-2009

AAPS - trends in turbulent times

AAPS 2009 has drawn to a close but over the three days numerous trends and debates emerged, including the strategies CROs are using in the downturn, and we take a look at these in our conference round up.

Published: 12-Nov-2009

AAPS - round up of day one

AAPS - round up of day one

Following the first full day of AAPS 2009 in Los Angeles, California, US we take a look at the major developments and talking points.

Published: 10-Nov-2009

OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009

OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009

Gerben Moolhuizen, OctoPlus and Hans Baumeister, Glycotope

James Easson, Merk KGaA - Shirley Dann, SCM Pharma

How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event.

Published: 29-Oct-2009

CPhI 2009 - Road to recovery?

CPhI 2009 - Road to recovery?

As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success.

Published: 15-Oct-2009

Gene therapy to drive viral and biologics market, says SAFC

Gene therapy to drive viral and biologics market, says SAFC

David Backer

Business development and marketing director - SAFC Pharma

SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.

Published: 14-Oct-2009

CPhI 2009 show preview

CPhI 2009 show preview

We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.

Published: 08-Oct-2009

Transcrip offers experts to augment in-house drug development

Transcrip offers experts to augment in-house drug development

Paul Branthwaite

Senior partner - TranScrip Partners

Transcrip Partners’ “augmentation” solution for contract R&D “differs from the normal consultancy alternative by fielding ‘doers’ who can think strategically and ‘thinkers’ who are happy to get their hands dirty” according to senior partner Paul Branthwaite.

Published: 09-Sep-2009

Symyx launches CDMO

Symyx launches CDMO

Eric Carlson, vice president, life science technology

Matthew Pino, director, business operations - Symyx

At BIO 2009 Symyx was promoting its new CDMO offering, which it believes meets a “real need in the industry” and can save clients time and materials by leveraging its prior knowledge.

Published: 03-Jun-2009

BerGenBio presents CellSelectRNAi tech at BIO 2009

BerGenBio presents CellSelectRNAi tech at BIO 2009

Richard Godfrey

CEO - BerGenBio,

The Norway-based company was spun out of Bergen University a few months ago but its tools, which it believes give more information on a target than any other currently available tech, have already attracted interest from biotechs in Europe, the US and Asia.

Published: 20-May-2009

Quotient Bioresearch buys Edinburgh facility and sets up new clinical unit

Quotient Bioresearch buys Edinburgh facility and sets up new clinical unit

Mark Egerton

Managing director - Quotient Clinical

UK CRO Quotient Bioresearch has bought a clinical research facility in Edinburgh, Scotland, which in conjunction with an existing unit in Nottingham, England will serve as a base for its new Quotient Clinical unit.

Published: 20-May-2009

Cisiv launches Baseline Plus for "real world" trials

Cisiv launches Baseline Plus for "real world" trials

Dominic Farmer

CEO - Cisiv

UK software group Cisiv has unveiled a web-based EDC platform, Baseline Plus, which is specifically tailored to meet the demands of post market trials.

Published: 07-May-2009

Packaging feeling effects of downturn, says Alcan pharmaceutical packaging president

Packaging feeling effects of downturn, says Alcan pharmaceutical packaging president

Michael Schmitt

President, Food Americas and Global Pharmaceuticals - Alcan Packaging

Michael Schmitt, president of Alcan Global Pharmaceutical Packaging, believes a recovery in the global economy, the increasing demand for quality and the emergence of markets like India and Brazil will be key drivers for the packaging sector over the next few years.

Published: 23-Mar-2009